Application of self-amplifying mRNA technology in the development of infectious disease vaccines
Chinese Science Bulletin · 01.11.2024 · 69 (33) · 4889-4904
DOI: 10.1360/tb-2023-0902 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chinese Science Bulletin, online erschienen am 17.10.2023. Verfasst von Xiaodan Li und 2 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 109 Literaturangaben.
Abstract (Originalsprache)
mRNA疫苗是下一代疫苗的重要平台,其安全有效和研发周期短的特点在应对新发传染病和其他疾病治疗方面具有巨大优势。复制型mRNA(saRNA)是从正链RNA病毒基因组衍生而来的具有自我复制能力的mRNA,能够以低剂量注射实现高水平的目的蛋白表达。基于saRNA的疫苗有潜力解决常规非复制型mRNA疫苗使用剂量大和重复接种的问题。近年来,saRNA合成、载体优化、及递送等技术发展迅速,大大推进了saRNA疫苗的发展,目前有多种传染病saRNA疫苗正在研发中。本文介绍了saRNA疫苗的作用机制和递送方式,对近年来针对病毒性传染病的saRNA疫苗进行综述,总结了saRNA疫苗设计的一般策略和优化方法,讨论了saRNA疫苗研发面临的挑战,并展望了saRNA在传染病防治中的其他研究方向,以期为saRNA在传染病防治中的应用提供借鉴。
Zitieren
APA
Li, X., Wang, X., & Zhang, B. (2024). Application of self-amplifying mRNA technology in the development of infectious disease vaccines. Chinese Science Bulletin, 69(33), 4889-4904. https://doi.org/10.1360/tb-2023-0902
Vancouver
Li X, Wang X, Zhang B. Application of self-amplifying mRNA technology in the development of infectious disease vaccines. Chinese Science Bulletin. 2024;69(33):4889-4904. doi:10.1360/tb-2023-0902
BibTeX
@article{Li2024,
author = {Li, Xiaodan and Wang, Xin and Zhang, Bo},
title = {Application of self-amplifying mRNA technology in the development of infectious disease vaccines},
journal = {Chinese Science Bulletin},
year = {2024},
volume = {69},
number = {33},
pages = {4889--4904},
doi = {10.1360/tb-2023-0902}
}
EUVIMED